MedPath

Haleon

Haleon logo
🇬🇧United Kingdom
Ownership
Public
Established
2022-01-01
Employees
25.4K
Market Cap
-
Website
http://www.haleon.com
Introduction

Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.

An Erosion Study to Investigate the Efficacy of an Experimental Dentifrice to Remineralize Enamel

Not Applicable
Completed
Conditions
Tooth Erosion
Interventions
Drug: Experimental Dentifrice
Drug: Placebo Control Dentifrice
Drug: Reference Dentifrice
First Posted Date
2024-02-05
Last Posted Date
2024-05-16
Lead Sponsor
HALEON
Target Recruit Count
33
Registration Number
NCT06242444
Locations
🇺🇸

Oral Health Research Institute, Indianapolis, Indiana, United States

A Study Assessing the Effects of an Experimental Dentifrice in Maintaining Tooth Color Following Tooth Bleaching

Not Applicable
Completed
Conditions
Oral Hygiene
Dentin Sensitivity
Interventions
Drug: Reference Dentifrice (Aquafresh Cavity Protection)
Drug: Test Dentifrice
First Posted Date
2023-11-29
Last Posted Date
2024-07-31
Lead Sponsor
HALEON
Target Recruit Count
160
Registration Number
NCT06150573
Locations
🇺🇸

Silverstone Research Group, Las Vegas, Nevada, United States

A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks

Not Applicable
Completed
Conditions
Gingivitis
Interventions
Drug: Stannous fluoride toothpaste
Drug: Sodium fluoride toothpaste
First Posted Date
2023-11-22
Last Posted Date
2024-03-28
Lead Sponsor
HALEON
Target Recruit Count
162
Registration Number
NCT06143670
Locations
🇺🇸

Salus Research, Fort Wayne, Indiana, United States

A Real-World Evidence Study Evaluating Oral Health Related Quality Of Life With Use Of A Stannous Fluoride Anti-Sensitivity Toothpaste For Dentin Hypersensitivity Management

Not Applicable
Completed
Conditions
Dentin Sensitivity
Interventions
Other: Stannous fluoride
First Posted Date
2023-09-21
Last Posted Date
2024-05-01
Lead Sponsor
HALEON
Target Recruit Count
536
Registration Number
NCT06045026
Locations
🇺🇸

ObvioHealth Virtual Site, New York, New York, United States

A Study to Evaluate the Effect of a Stannous Fluoride Toothpaste on the Oral Microbiome

Not Applicable
Completed
Conditions
Oral Health
Interventions
Other: Stannous Fluoride Toothpaste (Sensodyne Repair and Protect)
Other: Regular Fluoride Toothpaste (Colgate Cavity Protection)
First Posted Date
2023-09-21
Last Posted Date
2024-07-16
Lead Sponsor
HALEON
Target Recruit Count
55
Registration Number
NCT06048809
Locations
🇺🇸

Salus Research, Fort Wayne, Indiana, United States

A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentine Hypersensitivity in a Chinese Population

Not Applicable
Completed
Conditions
Dentin Sensitivity
Interventions
Drug: Sensodyne Sensitivity & Gum
Drug: Crest Cavity Protection Fresh Lime
Drug: Sensodyne Repair and Protect
First Posted Date
2023-03-02
Last Posted Date
2024-11-20
Lead Sponsor
HALEON
Target Recruit Count
416
Registration Number
NCT05750745
Locations
🇨🇳

Department of Preventive Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects

First Posted Date
2023-02-21
Last Posted Date
2023-05-31
Lead Sponsor
HALEON
Target Recruit Count
84
Registration Number
NCT05737069
Locations
🇨🇳

Clinical Pharmacological Research Center, Wenjiang, Chengdu, China

A Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) Compared to the Current Marketed Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) in Healthy Adult Subjects Under Fasted Conditions

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2023-01-06
Last Posted Date
2024-08-23
Lead Sponsor
HALEON
Target Recruit Count
77
Registration Number
NCT05674721
Locations
🇺🇸

Syneos Health, Miami, Florida, United States

A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal

Not Applicable
Completed
Conditions
Gingivitis
Dental Plaque
Interventions
Drug: Colgate Cavity Protection Dentifrice
Drug: Corsodyl Original Dentifrice
First Posted Date
2022-12-16
Last Posted Date
2023-12-20
Lead Sponsor
HALEON
Target Recruit Count
204
Registration Number
NCT05654662
Locations
🇬🇧

University of Bristol, Bristol Dental School and Hospital, Bristol, United Kingdom

Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

Phase 4
Completed
Conditions
Common Cold
Interventions
Drug: Otrivine Congestion Relief
First Posted Date
2022-09-27
Last Posted Date
2024-05-17
Lead Sponsor
HALEON
Target Recruit Count
136
Registration Number
NCT05556148
Locations
🇬🇧

The VCTC, Swadlincote, Derbyshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath